INTEGRATED BIOPHARMA INC 8-K

What Happened

• Integrated Biopharma, Inc. (INBP) filed a Form 8‑K dated April 15, 2026 (Accession No. 0001437749-26-012368) reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
• The filing furnishes — and does not file — the Company’s Inline XBRL cover page (Exhibit 104) and an exhibit index. No earnings, executive changes, mergers, or other material operational events are disclosed in this 8‑K.

Key Details

• Filing date: April 15, 2026; Accession No.: 0001437749-26-012368.
• Items reported: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits).
• Exhibit included: 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
• The information is explicitly "furnished, and not filed," which affects legal incorporation and liability.

Why It Matters

• This is an administrative filing primarily delivering machine‑readable (Inline XBRL) data and exhibit information; it does not announce financial results, management changes, or transactions that would typically affect near‑term investment decisions.
• Investors should view this as a compliance/formatting update that improves data accessibility rather than a substantive corporate development.